205 related articles for article (PubMed ID: 1468345)
1. Management of hypertension.
Kaplan NM
Dis Mon; 1992 Nov; 38(11):769-838. PubMed ID: 1468345
[TBL] [Abstract][Full Text] [Related]
2. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
3. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
[TBL] [Abstract][Full Text] [Related]
4. Changing hypertension treatment to reduce the overall cardiovascular risk.
Kaplan NM
J Hypertens Suppl; 1990 Dec; 8(7):S175-9. PubMed ID: 2095387
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
[TBL] [Abstract][Full Text] [Related]
6. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
7. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
8. Management of vascular risk factors in the hypertensive patient.
Taylor SH
J Hum Hypertens; 1990 Oct; 4 Suppl 3():10-6. PubMed ID: 2148191
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of hypertension in obesity.
Narkiewicz K
Obes Rev; 2006 May; 7(2):155-62. PubMed ID: 16629872
[TBL] [Abstract][Full Text] [Related]
10. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in obesity.
Redon J
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
13. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
14. Resistant hypertension: an overview of evaluation and treatment.
Sarafidis PA; Bakris GL
J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive therapy: why and how?].
Mancia G; Grassi G
Arch Mal Coeur Vaiss; 1997 Sep; 90 Spec No 5():41-4. PubMed ID: 9436519
[TBL] [Abstract][Full Text] [Related]
16. [Antihypertensive therapy in the nineties].
Weidmann P; Ferrari P
Schweiz Rundsch Med Prax; 1992 Feb; 81(7):188-98. PubMed ID: 1535954
[TBL] [Abstract][Full Text] [Related]
17. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of arterial hypertension: 1993 recommendations].
Leeman M
Rev Med Brux; 1994; 15(4):236-40. PubMed ID: 7938996
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metabolic syndrome.
Wagh A; Stone NJ
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
